VST BIO Corporation Announces Series A Financing to Advance VB-001 and Adds William Sessa to Board of Directors [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
closing of its Series A financing, led by Coefficient Giving, a philanthropic funder and advisor that partners with donors on cost-effective, high-impact giving across issues such as global health, science R&D and more. Coefficient Giving funding partners have invested a total of $45MM since the company's inception in 2020. Proceeds from the Series A will enable the company to advance its lead program into first-in-human studies in 2026, expand its platform, and build core development capabilities. (PRNewsfoto/VST Bio Corporation) "We are pleased to have completed this financing to support advancement of VB-001 for the benefit of stroke patients," said Krisztina Zsebo Ph.D., CEO and Chairman of the Board of VST BIO. Dr. Zsebo continued, "The positive results of our monoclonal antibody in stroke preclinical studies demonstrated the potential of VB-001 to become an important treatment for patients with acute ischemic stroke." As part of the financing, VST BIO has appointed William
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer Prostate Cancer Data Adds Context To Valuation And Pipeline Outlook [Yahoo! Finance]Yahoo! Finance
- Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLCBusiness Wire
- Pfizer aims for wider use of PARP drug in prostate cancer with new data [Yahoo! Finance]Yahoo! Finance
- The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients [Fortune]Fortune
- TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate CancerBusiness Wire
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 3/16/26 - Form 4
- 3/12/26 - Form ARS
- 3/12/26 - Form DEFA14A
- PFE's page on the SEC website